These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7438116)

  • 1. Proceedings of the 7th Lilly Vinca Alkaloid Symposium on Vindesine Washington, D.C., 6-7 October 1979.
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():1-93. PubMed ID: 7438116
    [No Abstract]   [Full Text] [Related]  

  • 2. Vindesine effect in myeloid leukemia.
    Baccarani M; Zaccaria A; Corbelli G; Tura S
    Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer.
    Gad-El-Mawla N; Hamza MR; El-Serafi M; El-Khoudary A; Aboul-Einein M; El-Demerdash S
    Cancer Treat Rep; 1983 Mar; 67(3):316-7. PubMed ID: 6831481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
    Palangie T; Jouve M; Giralt E; Bretaudeau B; Pouillart P
    Bull Cancer; 1983; 70(5):437-8. PubMed ID: 6582941
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
    Retsas S; Thomas C; Hobbs JR
    Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects of new chemotherapies].
    Sculier JP; Klastersky J
    Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
    [No Abstract]   [Full Text] [Related]  

  • 13. Vindesine trials at Memorial Sloan-Kettering Cancer Center.
    Young CW
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():53-7. PubMed ID: 7438122
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I and II studies of vindesine.
    Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 16. EORTC phase II trial of vindesine in advanced melanoma.
    Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
    [No Abstract]   [Full Text] [Related]  

  • 17. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
    Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 19. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vindesine in the treatment of refractory haematological malignant diseases.
    Young GA; Jurd J; Vincent PC
    Med J Aust; 1985 Feb; 142(3):189-90. PubMed ID: 3969034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.